ANMAT prohibited the sale of several medical products considering them illegal

ANMAT prohibited the sale of several medical products considering them illegal

October 18, 2024 – 10:00

These are products without an expiration date. After the investigation, it was also detected that they did not have the corresponding health records.

The National Administration of Drugs, Food and Medical Technology (ANMAT) prohibited the distribution and marketing of electroscalpels. The decision was known through the Provision 9188/2024 published in the Official Gazette. The complaint arrived from a routine check that he Market Control Department carried out a routine inspection at the firm’s headquarters PROVEMEDICA SA.

Furthermore, the products They did not have authorization, owner in the country, brand, or manufacturer. From there, photographic views of the units were taken and they were left in the establishment preventively inhibited from use and distribution.

The inspectors confirmed that it was observed that the expiration date was found crossed out with a thick black line.

What products were identified

During the operation the following products were identified:

  • MSB® Electrosurgical Electrodes, BQ70W5, LOT 20090803, MSB Medical (Wuhan) Co., Ltd.;
  • MSB® Electrosurgical Electrodes, BZ70, LOT 20090802, MSB Medical (Wuhan) Co., Ltd.;
  • MSB® Electrosurgical Electrodes, BD70, LOT 19030501, MSB Medical (Wuhan) Co., Ltd

What the ANMAT said about the confiscated electroscalpels

He release of ANMAT indicated that “The person in charge of the company reported that the products were imported in the past by the firm and that they did not have a health record.” Regarding the crossed out expiration dates, he explained that “they had carried out this procedure in order to “not guarantee or offer sterile products.”

In this way, the control entity prohibited the distribution and sale of products until the situation is regularized.

Product-ANMAT (1).jpg

Regarding the supplement, its use was prohibited

Regarding the supplement, its “preparation, fractionation and commercialization” was prohibited.

ANMAT prohibited the production and sale of a Peruvian “anti-cancer” supplement

The ANMAT also recently prohibited the “preparation, fractionation and marketing” of the supplement throughout the country. “anticancer Graviola, Provenza brand“. The College of Pharmacists of the province of Buenos Aires accused the manufacturing brand of not complying with food regulations.

Source: Ambito

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts

What products led the climbing

What products led the climbing

The FAO indicator, which follows monthly changes in international prices of a set of food products, averaged 128 points in June, that is, 0.5% more